An in vitro discharge study was conducted in triplicate at 32 ℃ across a cellulose dialysis membrane. In summary, various formulations of PLGA nanoparticles (equivalent to 3 mg of DH) (Salem et al.
Rights and permissions
The equation below was employed to estimate the EE% of the DH NPs (1). The average NP size (z-ave), polydispersity index (PDI), and zeta potential of DH-PLGA-NP were evaluated using dynamic light scattering (DLS) in a Nano ZS Zetasizer (Malvern Instruments, Malvern, UK). Before the measurement, each sample was attenuated by the addition of deionized water. The analysis was conducted at ambient temperature (25 ± 2 °C). The mean values ± SD were determined by scanning each specimen three times. 2020b) and glass cylinders (6 cm in length and 2.5 cm in internal diameter) were introduced and sealed at one end with a dialysis membrane with a molecular weight cutoff of 12,000 Da.
- Manufactured by pharmaceutical companies
- Active ingredient is dapoxetine
- Film-coated tablet formulation
- Includes inert excipients
- Produced under GMP standards
- Batch testing required
- Quality control measures
- Standardized dosage strength
- Supply chain logistics
- Manufacturer details on packaging
- Regulatory compliance
- Pharmaceutical grade
Overnight, the membrane was submerged in the receptor milieu. The laden cylinders were secured using the shafts of the USP dissolution tester apparatus (Abdelrahman et al. Thirty milliliters of simulated nasal electrolyte solution (SNES) with a pH of 5.5 were employed as the release medium to ensure sink conditions (Aboelwafa et al. 2H2O and a pH of 5.5 were also added (Cheng et al. The rotation speed was modified to 100 rpm, and the temperature was set to 32 ± 0.5 °C during the release research. To ensure a consistent volume, 3 ml aliquots were removed from the release medium and replaced with an equivalent volume of fresh medium at 0.5, 1, 2, 3, 4, 6, and 8 h later. The concentration of DH was determined by spectrophotometry at λmax 292 nm following the filtration of samples using a 0.45 m Millipore filter. The results of the release research were presented as means ± standard deviations for each formulation, and they were conducted in triplicate.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Cialis Generic | 40mg | 60 + 6 Pills | 130.98€ 124.74€ | |
| Priligy Generic Dapoxetine | 60mg | 180 + 10 Pills | 494.76€ 471.20€ | |
| Cialis Super Active | 20mg | 90 + 10 Pills | 314.14€ 299.18€ | |
| Priligy Generic Dapoxetine | 60mg | 20 + 4 Pills | 77.31€ 73.63€ | |
| Viagra Generic | 50mg | 20 Pills | 40.52€ 38.59€ | |
| Priligy Generic Dapoxetine | 60mg | 120 + 10 Pills | 341.26€ 325.01€ | |
| Cialis Original | 20mg | 48 + 4 Pills | 224.69€ 213.99€ | |
| Priligy Generic Dapoxetine | 60mg | 60 + 8 Pills | 183.06€ 174.34€ | |
| Priligy Generic Dapoxetine | 60mg | 30 + 6 Pills | 106.65€ 101.57€ | |
| Priligy Generic Dapoxetine | 60mg | 10 Pills | 47.63€ 45.36€ | |
| Levitra Generic | 20mg | 270 + 10 Pills | 376.33€ 358.41€ | |
| Cialis Soft Tabs | 20mg | 10 Pills | 39.03€ 37.17€ | |
| Priligy Generic Dapoxetine | 60mg | 90 + 10 Pills | 265.64€ 252.99€ | |
| Apcalis SX Oral Jelly | 20mg | 30 + 5 Sachets | 141.84€ 135.09€ | |
| Viagra Oral Jelly | 100mg | 220 + 18 Sachets | 562.28€ 535.50€ | |
| Levitra Generic | 60mg | 360 + 10 Pills | 906.69€ 863.51€ |
The cumulative percentage of DH-loaded PLGA NPs that were emitted was plotted against time.
| Parameter | Description | Typical Values |
|---|---|---|
| Absorption Rate | Time to reach peak plasma levels | ~1.5 hours |
| Bioavailability | Percentage of dose reaching systemic circulation | ~42% |
| Half-life | Time for plasma concentration to reduce by half | ~20 hours |
| Metabolism | Liver processing via CYP2D6 and CYP3A4 | CYP enzymes involved |
The mechanism of DH release from its PLGA NPs was determined by fitting the acquired data to zero-order, first-order kinetics, and the Higuchi diffusion model. The orders of release were subsequently established by determining the magnitude of the coefficients of determination (R2) in each instance and subsequently selecting the appropriate mathematical model. The local Animal Ethics Committee of Nahda University approved this investigation.
IELT scores
The double emulsion (w/o/w) method, as described by Zambaux et al. The following ingredients were used to produce a variety of PLGA NPs for DH: PLGA (25, 50, and 75 mg), PVA (1, 1.5, and 2% w/v), and aqueous internal phase volume (0.5, 0.75, and 1 ml) (Abdelkader et al. Separately, PLGA was dissolved in 0.5 ml of dichloromethane (organic phase), and the internal aqueous phase was formed by adding 1% w/v Span 80 and 30 mg DH to distilled water and agitating under magnetic agitation at ambient temperature. The dichloromethane was extracted under reduced pressure after 15 min of magnetic agitation. The primary emulsion (w/o) was generated by adding organic solvent containing PLGA to the internal aqueous phase in a drop-by-drop manner using a magnetic stirrer.
Phosphodiesterase 5 inhibitors
Subsequently, the tadalafil dapoxetine aqueous external phase was generated by dissolving 10 ml of distilled water with PVA using a magnetic stirrer. Lastly, the primary emulsion was homogenized at 13,500 rpm for 10 min while being drizzled onto the aqueous external phase at a constant rate until the formation of w/o/w. The EE% of DH-loaded PLGA NPs was indirectly estimated by subtracting the free DH (non-entrapped drug) from the total amount of DH that was actually added to the formulation. At 4 °C, the NPs were subjected to a cooling centrifugation (SIGMA 3–30 K, Steinheim, Germany) at 14,000 rpm for 1.5 h (Ahmed et al. The concentration of residual free DH in the filtrate was determined spectrophotometrically at λmax 292 nm after an appropriate dilution. Camel buccal mucosa was obtained from a nearby slaughterhouse and utilized within one hour of the animal’s death. Distilled water was used to collect the nasal mucosa of the camel that had been recently removed, with the exception of the septum (El-Nabarawi et al.
| Measure | Improvement Percentage | Measurement Tool | Notes |
|---|---|---|---|
| Ejaculation Control | Up to 70% | Patient satisfaction surveys | Significant for many |
| Confidence During Sex | 65-75% | Self-report questionnaires | Boosts performance perception |
| Partner Satisfaction | 60-70% | Partner feedback forms | Improved intimacy |
For 30–60 min, the membrane was equilibrated in distilled water (El-Nabarawi et al. The nasal membrane was recognized, and the superior nasal concha was subsequently isolated. The vertical Franz diffusion cell was then used dapoxetine tadalafil tablets to place the superior nasal membrane that had been excised.
| Interaction | Effect | Advice |
|---|---|---|
| SSRIs | Increased risk of side effects | Consult doctor before combining |
| CYP3A4 Inhibitors | Elevated dapoxetine levels | Dose adjustment recommended |
| Alcohol | Increased dizziness, risk of side effects | Avoid alcohol during treatment |
A Franz diffusion cell with a surface area of 5 cm2 was employed for ex vivo diffusion investigations. The nasal membrane surface was only briefly flooded with the diffusion fluid by maintaining the temperature of the chamber, which contained 100 ml of distilled water, at 37 ± 0.5 °C and agitating continuously with a magnetic bar at 100 rpm.
Special Dietary & Lifestyle Recommendation
The rapid-acting DH and the targeted IN formula for the ejaculation centre in the brain were the primary findings of the study. These findings were confirmed by sexual behavioural tests (extension of the intra-ejaculation duration), immunohistochemistry (FOS protein density %), and histology (Hippocampus). This research is of the utmost importance in the field of sexual medicine for patients with controlled DH release who have normal or diabetic PE. In the form of a purified powder salt, dapoxetine HCl was generously provided by Spimaco Addwaeih (Riyadh, Saudi Arabia) without any excipients, additives, or preservatives. Obtained from the Arab pharma company Al Amriya in Cairo, Egypt, Lidocaine Topical Aerosol; puritans pride premium, Yohimbine (Yohimbe 2000®).
16. Is Dapoxetine used for depression?
Dialysis tubes with a molecular weight cut-off of 12,000 Da were procured from SERVA Electrophoresis GmbH (Heidelberg, Germany). Every other reagent was of the highest quality to be found. The Box–Behnken design was developed by the Design Expert® software (Version 11, Stat-Ease Inc. Minneapolis, MN). The design contains three levels and three factors.
Storage Class
In order to generate PLGA NPs models, a group of 15 experimental trials was necessary. The concentration of aqueous external phase (PVA) (B), the volume of aqueous internal phase (C), and the quantity of PLGA polymer (A) were the independent variables that were examined. The dependent variables were the cumulative quantity of DH permeated/unit area in 24 h (Q24) (Y4), particle size (Y2), release over 8 h (Y3), and EE% (Y1). The independent variables that are the subject of this investigation are listed in Table 1, along with their low, medium, and high levels. These levels were selected based on the results of preliminary experiments. The investigation was conducted in non-occlusive conditions. Various volumes of PLGA NP dispersion containing constant quantities of DH (3 mg) were introduced into the donor compartment of the Franz diffusion cell. At predetermined intervals (1, 2, 3, 4, 5, 6, 8, 12, and 24 h), no more than 3 ml of receptor compartment samples were extracted and replaced with equivalent volumes of new milieu.
Shelf-Life, Storage, Dosage Form
PLGA, a biocompatible and biodegradable polymer, is extensively employed for the therapeutic delivery of hydrophilic and hydrophobic drugs. Polymeric NPs are produced from this polymer (Md et al. PLGA has the potential to safeguard medications from degradation in the nasal cavity. PLGA has been employed for controlled drug release purposes for decades, making it an evident choice for the encapsulation of numerous pharmaceuticals used to treat brain disorders (Sharma et al. To the best of our knowledge, no published research has evaluated the therapeutic effects of intranasal administration of PLGA nanoparticles containing DH in an experimental model of premature ejaculation.
6. How often can Dapoxetine be taken?
However, previous studies have attempted to increase the efficacy and treatment of PE by combining multiple drugs, as shown by Olivier (Olivier et al. In another investigation, all of the pharmaceuticals used for PE treatment were illustrated; however, none of them were tested for the IN nanoformulation and treatment (McMahon 2016). An additional molecule, Modafinil, was initially identified as a wake-promoting agent in a separate study and is currently employed to treat narcolepsy. The mechanism of action of modafinil is intricate and inadequately comprehended, and it appears to involve the induction of alterations in brain activation (Ballon and Feifel 2006). Our research is focused on the systematic development of PLGA nanoparticles that are specifically designed to target the CNS and are intended for intravenous administration to treat premature ejaculation.
In vivo study of optimized DH-PLGA NP in yohimbine-induced premature ejaculation in normal and diabetic rats
The double emulsion-solvent evaporation method was employed to incorporate DH in PLGA nanoparticles using the Box-Behnken design. The DH-PLGA NPs were assessed for ex vivo drug permeation, in vitro drug release, particle size, and EE%. One of our objectives in this investigation is to resolve the issue of premature ejaculation in males by directly targeting the dapoxetine substance to the dapoxetine sex brain through passive targeting. The substance is able to reach the brain rapidly and directly through passive diffusion from the nasal tract, circumventing the blood–brain barrier, with IN administrations. The efficacy and speed of this treatment surpass those of conventional dapoxetine treatments. Lastly, the samples were analysed at 292 nm using a spectrophotometer after being filtered through a 0.45-m Millipore filter. The total quantity of DH penetrated per unit area (g/cm2) was plotted against time (h) for each formulation. For each DH-PLGA-NP and the control DH solution, the permeation parameters Q24 in g/cm2, latency time in minutes, permeability coefficient (Kp) in cm/h, and drug flux (Jss) in g/cm2 h were determined. Additionally, the following formula was employed to calculate the enhancement index (EI) (El-Nabarawi et al. The optimized DH-PLGA-NP was subjected to a morphological investigation using a JEM-1400 transmission electron microscope (Jeol, Tokyo, Japan). A drop of the Nano dispersion was deposited on a copper grid after it had been adequately diluted, and the excess was removed using filter paper.
- Not approved for use in children
- Safety not established in minors
- Not for use under 18 years
- Dosage unknown for children
- Risk of side effects high
- Off-label use only
- Consult pediatrician
- Do not use in pediatric population
- Safety data lacking
- Risk to developing brain
- Strictly off-label use
- Not recommended for children